Dermavant Sciences initiates phase III study of tapinarof for the treatment of plaque psoriasis June 3, 2019 No Comments
Results of phase IIb trial of topical PAC-14028, a TRPV1 antagonist, in atopic dermatitis May 28, 2019 No Comments
FLX Bio presents a novel CCR4 antagonist for the treatment of allergic disorders May 21, 2019 No Comments
Proof of concept achieved for KB-103 as topical treatment for epidermolysis bullosa dystrophica May 17, 2019 No Comments
Phase III study of abrocitinib in atopic dermatitis meets all coprimary and secondary endpoints May 15, 2019 No Comments
RSS